You are here: Industry Insights > vaccine

News List

Huons acquires marketing rights for Sputnik Light in S. Korea firstwordpharma
July 08, 2021
Huons Global has secured marketing rights for Russia's COVID-19 vaccine Sputnik Light in South Korea, said The Korea Herald.
COVID Vaccine Doesn't Infiltrate Breast Milk drugs
July 07, 2021
Women who are breastfeeding and wonder if COVID-19 vaccination is safe for their baby may be reassured by the results of a new study.
Recipharm selected to operate new fill/finish facility in Morocco cphi-online
July 07, 2021
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate prnewswire
July 07, 2021
Dynavax Technologies Corporation today announced the execution of a commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant, for use in BE's subunit COVID-19 vaccine candidate, CORBEVAX?.
Researchers find potential path to a broadly protective COVID-19 vaccine using T cells firstwordpharma
July 06, 2021
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.
Ministry data said to show Pfizer shot blocks majority of serious Delta cases firstwordpharma
July 06, 2021
A study from researchers at Hebrew University and Hadassah University Medical Center suggest Pfizer and BioNTech's COVID-19 vaccine is 60% to 80% effective against infection from the Delta variant, reported The Times of Israel.
Gap between Covid jabs to be reduced to eight weeks for all under-40s firstwordpharma
July 06, 2021
New UK health secretary Sajid Javid told lawmakers "we are reducing the dose interval [for COVID-19 vaccines] for under-40s from 12 weeks to eight," as reported in This is Money.
France's Sanofi expects Covid vaccine to be ready by December firstwordpharma
July 06, 2021
Sanofi says its GlaxoSmithKline-partnered COVID-19 vaccine should be available by December, reported RFI. The vaccine uses recombinant proteins to trigger an immune response – the same technology that is used in one of Sanofi's seasonal influenza vaccines
Celltrion expects Covid variants to fuel global treatments growth firstwordpharma
July 06, 2021
Celltrion is betting that new variants of the coronavirus will fuel growth in the US and Europe for treatments of the disease, Financial Times reported.
Morocco’s Sothema to produce China’s Sinopharm vaccine firstwordpharma
July 06, 2021
Moroccan pharmaceutical firm Sothema will soon start producing 5 million doses of Sinopharm's COVID-19 vaccine in the North African country, as reported in Yahoo!News.